Genetic Engineering & Biotechnology News

OCT15 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/883455

Contents of this Issue

Navigation

Page 3 of 37

For Research Use Only. Not for diagnostic use. RNAscope is a registered trademark of Advanced Cell Diagnostics, Inc. in the United States or other countries. All rights reserved. ©2016 Advanced Cell Diagnostics, Inc. Enabling Research, Drug Development & Diagnostics What's missing from your biomarker analysis? Complete the picture with RNAscope ® in situ hybridization. Visualize expression of immune checkpoint markers in the tissue microenvironment RNAscope ® in situ hybridization technology delivers unrivaled single-molecule sensitivity and specificity—with the multiplexing capability for the detection of multiple markers at once, enabling exquisite characterization of immune checkpoint markers in the tissue microenvironment. Same-day results and automated assays mean you can get the data you seek quickly, easily, and all backed by our performance guarantee. Learn more at acdbio.com/immunooncology

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - OCT15 2017